NEW YORK (GenomeWeb News) – Med Fusion today said that it has inked a validation and market development pact with Theranostics Health aimed at validating the clinical utility of Theranostics Health's personalized medicine assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.